An 8-week randomized controlled trial comparing the effect of a novel oscillating-rotating toothbrush versus a manual toothbrush on plaque and gingivitis.


Journal

International dental journal
ISSN: 1875-595X
Titre abrégé: Int Dent J
Pays: England
ID NLM: 0374714

Informations de publication

Date de publication:
Apr 2020
Historique:
entrez: 4 4 2020
pubmed: 4 4 2020
medline: 9 4 2020
Statut: ppublish

Résumé

To compare a novel oscillating-rotating (O-R) electric rechargeable toothbrush with micro-vibrations (Oral-B iO) to a manual brush for gingivitis and plaque reduction. Adult subjects with gingivitis and plaque were randomized to use either the O-R or the manual toothbrush with standard fluoride dentifrice twice daily. Efficacy was assessed at baseline, week 1, and week 8 using the Rustogi Modification of the Navy Plaque Index (RMNPI), Modified Gingival Index (MGI), and Gingival Bleeding Index (GBI). Gingivitis status ('healthy'/'not healthy') was also assessed, per the American Academy of Periodontology/European Federation of Periodontology criteria. One hundred and ten subjects were enrolled and completed the randomized controlled trial. The baseline mean number (SD) of bleeding sites for all subjects was 32.11 (16.703). At week 8, 82% of subjects using the O-R toothbrush were categorized as 'healthy' (<10% bleeding sites), versus 24% of subjects using the manual brush (P < 0.001). Subjects using the O-R toothbrush showed statistically significantly greater reductions (P < 0.001) in the number of bleeding sites, GBI scores and MGI scores versus those using a manual toothbrush as early as 1 week and throughout the 8-week study. The O-R toothbrush also provided statistically significantly greater reductions (P < 0.001) in all plaque measures, including sub-regions, versus the manual toothbrush after a single brushing and at weeks 1 and 8. The novel O-R electric toothbrush with micro-vibrations provided statistically significantly greater plaque and gingivitis reductions versus a manual toothbrush, with performance benefits demonstrated after a single brushing and continuing throughout the 8-week study.

Identifiants

pubmed: 32243573
doi: 10.1111/idj.12571
pmc: PMC9379164
doi:

Substances chimiques

Dentifrices 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

S7-S15

Subventions

Organisme : The Procter & Gamble Company

Informations de copyright

© 2020 FDI World Dental Federation.

Références

PLoS Pathog. 2015 Jul 30;11(7):e1004952
pubmed: 26226364
Ann Periodontol. 1999 Dec;4(1):7-19
pubmed: 10863371
J Periodontol. 2020 May;91(5):582-595
pubmed: 31554016
Clin Prev Dent. 1986 Jan-Feb;8(1):3-6
pubmed: 3485495
J Clin Periodontol. 2003 Oct;30(10):887-901
pubmed: 14710769
J Clin Dent. 2009;20(3):93-8
pubmed: 19711610
J Periodontol. 2015 May;86(5):611-22
pubmed: 25688694
J Periodontol. 2018 Jun;89 Suppl 1:S46-S73
pubmed: 29926936
J Clin Dent. 1992;3(Suppl C):C9-12
pubmed: 1306676
Int J Dent Hyg. 2019 May;17(2):153-160
pubmed: 30375187
J Periodontal Res. 1989 Jan;24(1):75-80
pubmed: 2524573
Br Dent J. 2019 Oct;227(7):621-625
pubmed: 31605074
Int J Dent Hyg. 2019 Nov;17(4):343-349
pubmed: 31125483
J Clin Dent. 2017 Mar;28(1 Spec No A):A13-28
pubmed: 28422461
BMC Oral Health. 2018 Aug 3;18(1):130
pubmed: 30075780
Am J Dent. 2010 Feb;23(1):9-13
pubmed: 20437720
J Clin Dent. 2015;26(3):80-5
pubmed: 26665291
Int J Dent Hyg. 2017 May;15(2):135-141
pubmed: 26799625
Am J Dent. 2020 Feb;33(1):3-11
pubmed: 32056408
J Clin Periodontol. 2004 Dec;31(12):1122-7
pubmed: 15560816
J Clin Dent. 2018 Mar;29(1):27-32
pubmed: 29758154
J Clin Periodontol. 2019 Jul;46(7):713-722
pubmed: 31115952
Am J Orthod Dentofacial Orthop. 2013 Jun;143(6):760-6
pubmed: 23726325
Am J Orthod Dentofacial Orthop. 2019 Apr;155(4):462-472
pubmed: 30935601
Angle Orthod. 2019 May;89(3):385-390
pubmed: 30516414
J Clin Dent. 2013;24(2):55-61
pubmed: 24282870
J Clin Periodontol. 2016 Apr;43(4):333-44
pubmed: 26810308
J Periodontol (1930). 1965 May-Jun;36:177-87
pubmed: 14296927
Am J Dent. 2012 Sep;25 Spec No A(A):21A-26A
pubmed: 23248895
J Clin Periodontol. 2015 Apr;42 Suppl 16:S77-91
pubmed: 25597787
Int J Dent Hyg. 2020 Feb;18(1):17-26
pubmed: 31050195
Int Dent J. 2020 Apr;70 Suppl 1:S22-S27
pubmed: 32243574
Am J Dent. 2012 Oct;25(5):287-92
pubmed: 23243977
Cochrane Database Syst Rev. 2014 Jun 17;(6):CD002281
pubmed: 24934383
J Periodontal Res. 2017 Aug;52(4):651-665
pubmed: 28177120
J Dent Res. 2003 Nov;82(11):929-32
pubmed: 14578508
Clin Oral Investig. 2004 Dec;8(4):206-10
pubmed: 15583919

Auteurs

Julie Grender (J)

The Procter & Gamble Company, Mason, OH, USA.

C Ram Goyal (C)

All Sum Research Center Ltd, Mississauga, ON, Canada.

Jimmy Qaqish (J)

All Sum Research Center Ltd, Mississauga, ON, Canada.

Ralf Adam (R)

Procter & Gamble Service GmbH, Kronberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH